Multi-center Study to Evaluate the Safety of Apixaban (BMS-562247) in Indian Subjects Undergoing Elective Total Knee Replacement or Total Hip Replacement Surgery

NCT01884337 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

557

Enrollment

INDUSTRY

Sponsor class

Conditions

Anticoagulation

Interventions

DRUG: Apixaban

Sponsor

Bristol-Myers Squibb

Collaborators

[object Object]